Story

TPG Explores $5 Billion Sale of Portfolio Company Lyric Amid Strong Stock Performance

ENTHMSVIIDZHZH-TWJAKOHI
Oct 1, 20261 min read
TPG Explores $5 Billion Sale of Portfolio Company Lyric Amid Strong Stock Performance
Text size
Background

Global alternative asset manager TPG Inc. (NASDAQ: TPG) is reportedly exploring a potential sale of Lyric, a healthcare software company in its portfolio, for as much as $5 billion, according to a report from Investing.com. This potential divestment is one of several recent monetization activities for the firm, which has seen its stock gain over 10% since the beginning of July.

Potential Asset Sale

The exploration of a sale for Lyric represents a significant potential move to realize value from TPG's private equity holdings. If completed at the reported valuation, the deal would mark a major asset monetization for the firm. This activity underscores a broader strategy of actively managing its portfolio to generate returns for its investors and shareholders.

In a separate transaction, TPG RE Finance Trust also recently priced a $1 billion commercial real estate collateralized loan obligation (CLO), signaling continued activity within its real estate credit division.

Sample IUX Markets – In-articleAd

Recent Financial Performance

TPG's stock has performed well in recent months, climbing +10.14% since July 1, 2026. The gains are supported by strong fundamental results, including a notable second-quarter earnings beat.

On August 4, the company reported Q2 earnings per share (EPS) of $0.82, surpassing the consensus analyst estimate of $0.60 by nearly 37%. Investors are now looking ahead to the company's next earnings report, scheduled for October 29, for further updates on its performance and strategic initiatives.

Read next

More on Stocks
Back to latest news

LATEST